A team of scientists has uncovered a critical mechanism that could pave the way for safer and more effective obesity ...
Levi Garraway, Roche's chief medical officer and head of global product development. Roche has built the evidence for its oral BTK inhibitor fenebrutinib in multiple sclerosis (MS) with two phase 3 ...
Oncogenic PI3Kα variants are key drivers of tumorigenesis; however, the conformational landscape of these mutants is not well characterized. Here, the authors use atomistic molecular dynamics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results